Top compounds associated with response to SLC2A13


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.021 0.7
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.015 0.7
mRNA TGX221 GDSC1000 pan-cancer AAC -0.021 0.7
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.022 0.7
mRNA GSK2126458 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA BMS-270394 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA TL-2-105 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.021 0.7
Download CSV